Fludzoparib" and Anti-angiogenic

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Fludzoparib" and Anti-angiogenic trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT06255392

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Inv…

This study develops a new therapeutic approach for HER2-negative advanced breast cancer patients without precise treatment targets. The trial aims at extending…

China200 participantsStarted 2024-06-12

Treatment: Fluzoparib, Apatinib Mesylate

Fludzoparib" and Anti-angiogenic

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Inv…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Inv…

All recent trials (1 shown)

Fludzoparib&#34; and Anti-angiogenic

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Inv…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Inv…

All recent trials (1 shown)

Fludzoparib" and Anti-angiogenic